A Dose of Success: Marksans Pharma Receives UK Approval for Gabapentin Innovation

Unknown Apr 02, 2026 4 Views

Marksans Pharma's wholly owned subsidiary has attained an important regulatory milestone with marketing authorization for Gabapentin 50 mg/ml Oral Solution-a flagship product for the treatment of epilepsy and neuropathic pain. The approval, made by the UK's Medicines and Healthcare produc...